Catalyst Wire Dossier Catalyst Wire Dossier

ZA-203

· Repros Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZA-203, covering 2013-05-17 to 2013-05-17. Get the full timeline:

Most recent: Clinical Trial Update: A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 [Phase 2]

See pricing